BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 24029422)

  • 1. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
    Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
    J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of the Klotho-miR-30s/TRPC6 axis confers podocyte injury.
    Qiu X; Huo J; Xia S; Zhao W; Luo Y; Xia Y
    Biochem Biophys Res Commun; 2021 Jun; 557():90-96. PubMed ID: 33862465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
    Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
    Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression.
    Liu L; Lin W; Zhang Q; Cao W; Liu Z
    J Mol Med (Berl); 2016 Mar; 94(3):291-300. PubMed ID: 26432290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes.
    Shi S; Yu L; Zhang T; Qi H; Xavier S; Ju W; Bottinger E
    PLoS One; 2013; 8(9):e75572. PubMed ID: 24086574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.
    Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z
    J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes.
    Wu J; Zheng C; Wang X; Yun S; Zhao Y; Liu L; Lu Y; Ye Y; Zhu X; Zhang C; Shi S; Liu Z
    J Clin Invest; 2015 Nov; 125(11):4091-106. PubMed ID: 26436650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate.
    Zheng Z; Hu H; Tong Y; Hu Z; Cao S; Shan C; Lin W; Yin Y; Li Z
    Cell Death Dis; 2018 Nov; 9(11):1133. PubMed ID: 30429458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
    Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
    Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
    Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
    Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-135 family members mediate podocyte injury through the activation of Wnt/β-catenin signaling.
    Yang X; Wang X; Nie F; Liu T; Yu X; Wang H; Li Q; Peng R; Mao Z; Zhou Q; Li G
    Int J Mol Med; 2015 Sep; 36(3):669-77. PubMed ID: 26134897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner.
    Yang X; Wu D; Du H; Nie F; Pang X; Xu Y
    Int J Mol Med; 2017 Nov; 40(5):1511-1519. PubMed ID: 28949388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-130b Alleviated Podocyte Injury Induced by Puromycin Aminonucleoside
    Qi CJ; Pan Y; Shen JX; Kuai QL; Zhu JX; Wang WP
    Ann Clin Lab Sci; 2021 May; 51(3):393-399. PubMed ID: 34162570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
    Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
    J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.
    Wada T; Pippin JW; Marshall CB; Griffin SV; Shankland SJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2615-25. PubMed ID: 15987750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.